Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease portal hypertension
Symptom C0023890|liver cirrhosis
Sentences 35
PubMedID- 21506350 An analysis of 115 liver cirrhosis patients with portal hypertension was made to find out which of them had variceal bleeding and high risk of its development.
PubMedID- 22114590 We have a long-lasting interest in applying endoscopic ultrasound for the study of features of portal hypertension in patients with liver cirrhosis .
PubMedID- 22957328 Liver elastography for the diagnosis of portal hypertension in patients with liver cirrhosis.
PubMedID- 21701671 She was a known case of cryptogenic liver cirrhosis with portal hypertension.
PubMedID- 20652243 Four patients underwent splenectomy because of liver cirrhosis with portal hypertension and gastroesophageal variceal bleeding.
PubMedID- 22009385 Background: portal hypertension associated with liver cirrhosis increases the risk of postoperative complications after liver resection for hepatocellular carcinoma (hcc).
PubMedID- 22577563 portal hypertension in liver cirrhosis results from the anatomical changes and the development of contractile element in the liver vascular bed secondary to progressive hepatic fibrosis and formation of regenerative nodules .
PubMedID- 25798930 Objective: to investigate the role of contrast-enhanced ultrasonography (ceus) and doppler ultrasonography (dus) in the diagnosis of severe portal hypertension (ph) in patients with liver cirrhosis (lc).
PubMedID- 25892988 This study aimed to further investigate portal venous remodeling in the pathogenesis of liver cirrhosis with portal hypertension, thereby guiding its prevention and treatment.
PubMedID- 24974920 So, the current study was conducted to evaluate cardiac systolic and diastolic functions in liver cirrhosis patients with portal hypertension by conventional doppler echocardiography and tdi.
PubMedID- 21705304 A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations).
PubMedID- 24673975 Thrombocytopenia: in time, liver cirrhosis leads to portal hypertension.
PubMedID- 26378453 portal hypertension may develop in patients with liver cirrhosis, as a result of an increased intrahepatic vascular resistance, reduced systemic vascular resistance and increased portal inflow.
PubMedID- 22591184 Soluble cd163, a marker of kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis.
PubMedID- 24729881 17 (7%) patients had a mild hepatic comorbidity (score 1) (bilirubin > uln to 1.5 × uln or ast/alt > uln to 2.5 × uln) and 1 patient additional liver cirrhosis with portal hypertension (score 3).
PubMedID- 21802316 Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization.
PubMedID- 24563796 Relevant diagnoses of the patient were (i) known hypertensive cardiac disease (transthoracic echocardiography 6 months before had shown a lv-ef of 54% and a light mitral and tricuspid insufficiency) and (ii) liver cirrhosis with portal hypertension.
PubMedID- 25374728 Variceal bleeding is the major complication of portal hypertension in patients with liver cirrhosis.
PubMedID- 24757655 Background/aims: this retrospective study assessed the clinical outcome of a transjugular intrahepatic portosystemic shunt (tips) procedure for managing portal hypertension in koreans with liver cirrhosis.
PubMedID- 23247799 1endoscopic appearance of small bowel lesions related to portal hypertension in patients with liver cirrhosis.
PubMedID- 22916658 portal hypertension and varices in patients with liver cirrhosis.
PubMedID- 24697006 In second pregnancy, medically induced abortion was performed in the 12th week because of deterioration of the underlying disease, liver cirrhosis with portal hypertension.
PubMedID- 21827004 Reconstructed cta images showed that different collateral vessels were developed at the end-stage of chronic liver cirrhosis due to severe portal hypertension.
PubMedID- 23855493 Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis.
PubMedID- 25933224 liver cirrhosis with portal hypertension is characterized by systemic and splanchnic vasodilatory substances release, especially nitric oxide (no) and prostacyclin 3, which lead to hyperdynamic circulatory status, and further increased mesenteric blood flow and portal inflow.
PubMedID- 25499848 Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis.
PubMedID- 22878372 This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis.
PubMedID- 25336484 Contrast-enhanced sonography for quantitative assessment of portal hypertension in patients with liver cirrhosis.
PubMedID- 25374673 Future therapy of portal hypertension in liver cirrhosis - a guess.
PubMedID- 26159275 This might explain the pathophysiologic correlation between microbial infections and portal hypertension in patients with liver cirrhosis.
PubMedID- 25888771 Introduction: esophagogastric varices bleeding is a common complication due to portal hypertension in patients with liver cirrhosis.
PubMedID- 23452051 Functional variants of enos and inos genes have no relationship to the portal hypertension in patients with liver cirrhosis.
PubMedID- 23729979 Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices.
PubMedID- 24914368 Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review.
PubMedID- 21460144 Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis.

Page: 1